傳碧桂園(02007.HK)大規模架構調整 合併逾20個區域公司
內媒引述消息人士指,碧桂園(02007.HK)計劃作出內部架構調整,涉及逾20個區域的分公司合併,以及38項人事調動及部門整合。
據指,架構調整已經內部討論約一年,部分業務規模偏小、地域鄰近的區域將合併為較大的區域公司,例如合併浙東區域、寧波區域為浙東區域;合併江蘇區域、蘇州區域、蘇南區域為江蘇區域;合併滬蘇區域、上海區域為滬蘇區域等。
此外,集團投資策劃中心、設計管理中心將合併為投資策劃中心,由集團常務副總裁、品牌營銷中心總經理程光煜擔任投資策劃中心總經理,並分管文商旅集團;原設計管理中心總經理楊翠瓏將改任成本管理中心總經理;博智林機器人公司執行總裁張志遠任湖南區域總裁等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.